1. Home
  2. UTMD vs TNXP Comparison

UTMD vs TNXP Comparison

Compare UTMD & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UTMD
  • TNXP
  • Stock Information
  • Founded
  • UTMD 1978
  • TNXP 2007
  • Country
  • UTMD United States
  • TNXP United States
  • Employees
  • UTMD N/A
  • TNXP N/A
  • Industry
  • UTMD Medical/Dental Instruments
  • TNXP Biotechnology: Pharmaceutical Preparations
  • Sector
  • UTMD Health Care
  • TNXP Health Care
  • Exchange
  • UTMD Nasdaq
  • TNXP Nasdaq
  • Market Cap
  • UTMD 185.2M
  • TNXP 173.9M
  • IPO Year
  • UTMD N/A
  • TNXP N/A
  • Fundamental
  • Price
  • UTMD $56.84
  • TNXP $18.49
  • Analyst Decision
  • UTMD
  • TNXP Buy
  • Analyst Count
  • UTMD 0
  • TNXP 1
  • Target Price
  • UTMD N/A
  • TNXP $70.00
  • AVG Volume (30 Days)
  • UTMD 7.0K
  • TNXP 851.8K
  • Earning Date
  • UTMD 10-23-2025
  • TNXP 11-07-2025
  • Dividend Yield
  • UTMD 2.15%
  • TNXP N/A
  • EPS Growth
  • UTMD N/A
  • TNXP N/A
  • EPS
  • UTMD 3.54
  • TNXP N/A
  • Revenue
  • UTMD $38,633,000.00
  • TNXP $9,831,000.00
  • Revenue This Year
  • UTMD N/A
  • TNXP $14.79
  • Revenue Next Year
  • UTMD N/A
  • TNXP $933.49
  • P/E Ratio
  • UTMD $16.01
  • TNXP N/A
  • Revenue Growth
  • UTMD N/A
  • TNXP N/A
  • 52 Week Low
  • UTMD $51.26
  • TNXP $6.76
  • 52 Week High
  • UTMD $68.99
  • TNXP $130.00
  • Technical
  • Relative Strength Index (RSI)
  • UTMD 31.71
  • TNXP 31.62
  • Support Level
  • UTMD $55.65
  • TNXP $18.53
  • Resistance Level
  • UTMD $60.68
  • TNXP $20.58
  • Average True Range (ATR)
  • UTMD 1.22
  • TNXP 1.09
  • MACD
  • UTMD -0.51
  • TNXP 0.41
  • Stochastic Oscillator
  • UTMD 19.26
  • TNXP 7.04

About UTMD Utah Medical Products Inc.

Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

Share on Social Networks: